ADMA BIOLOGICS, INC. business relationships
Companies named in ADMA BIOLOGICS, INC.’s 10-K filed 2026-02-25, and public companies whose annual reports name ADMA BIOLOGICS, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.9 / 10
- AI naming
- 25 / 100 Top 2% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in ADMA BIOLOGICS, INC.’s annual report 4
“In December 2018, our former contract manufacturer assigned its rights and obligations under the Plasma Supply Agreement to Grifols, effective January 2019.” SEC filing
“As of December 31, 2024, three customers, BioCare, Healix Infusion Therapy, LLC ("Healix") and Cencora, Inc. (f/k/a AmerisourceBergen Corporation), represented an aggregate of approximately 91% of our consolidated accounts receivable.” SEC filing
“First Amendment to License Agreement, dated as of June 6, 2017, by and between the Company and Biotest AG (incorporated herein by reference to Exhibit 10.8 to the Company's Quarterly Report on Form 10-Q, filed with the SEC on August 11, 2017).” SEC filing
“For the year ended December 31, 2025, two customers, BioCare, Inc. ("BioCare") and Priority Healthcare Distribution, Inc. ("CuraScript"), represented an aggregate of approximately 73% of our consolidated revenues.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.